NextCure股价因骨病治疗积极数据而飙升

英为财情
Jul 26, 2025

Investing.com -- NextCure Inc (NASDAQ:NXTC)股价上涨14%,此前该公司展示了其新型抗Siglec-15抗体NC605作为成骨不全症(OI,俗称脆骨病)潜在治疗方法的有前景的临床前数据。 这家临床阶段生物制药公司透露,在一个成熟的OI模型中,NC605与抗硬化蛋白治疗相比,显示出改善骨微结构和降低骨折发生率的效果。这些数据于2025年7月24日在脆骨病...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10